( SEVAMED 2001)

(Diagnosis, Diagnostics, Immunodiagnosis, Immunodiagnostics, Pathogenesis,  Vaccines & Drugs)

(Click Here for Abstract)

Back To Content Page

1254.      Agarwala S.  Mitra DK. Biliary atresia--the current management. [Review] [29 refs] Indian Journal of Pediatrics.  63(6):719-24, 1996 Nov-Dec.

1255.      Anonymous. WHO Expert Committee on Biological Standardization. World Health Organization Technical Report Series.  889:i-vi, 1-111, 1999.

1256.      Arbuthnot P.  Capovilla A.  Kew M. Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and  JAK/STAT pathways [see comments]. [Review] [130 refs] Journal of Gastroenterology & Hepatology.  15(4):357-68, 2000 Apr.

 1257.      Assy N.  Minuk GY. Serum aspartate but not alanine aminotransferase levels help to predict the histological features of chronic hepatitis C viral infections in adults. American Journal of Gastroenterology.  95(6):1545-50, 2000 Jun.

 1258.      Bautista AP. Impact of alcohol on the ability of Kupffer cells to produce chemokines and its role in alcoholic liver disease. [Review] [50 refs] Journal of Gastroenterology & Hepatology.  15(4):349-56, 2000 Apr.

 1259.      Bock HL.  Kruppenbacher JP.  Bienzle U.  De Clercq NA.  Hofmann F. Clemens RL. Does the concurrent administration of an inactivated hepatitis A vaccine influence the immune response to other travelers vaccines?. Journal of Travel Medicine.  7(2):74-8, 2000 Mar-Apr.

 1260.      Calabrese F.  Pontisso P.  Pettenazzo E.  Benvegnu L.  Vario A.  Chemello L.  Alberti A.  Valente M. Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels. Hepatology.  31(5):1153-9, 2000 May.

 1261.      Carrigan DR. Adenovirus infections in immunocompromised patients. [Review] [05 refs] American Journal of Medicine.  102(3A):71-4, 1997 Mar 17.

 1262.      Ciocca M.Clinical course and consequences of hepatitis A infection. Vaccine.  18 Suppl 1:S71-4, 2000 Feb 18.

 1263.      Dalekos GN.  Kistis KG.  Boumba DS.  Voulgari P.  Zervou EK.  Drosos AA. Tsianos EV. Increased incidence of anti-cardiolipin antibodies in patients with hepatitis C is not associated with aetiopathogenetic link to anti-phospholipid syndrome. European Journal of Gastroenterology & Hepatology.  12(1):67-74, 2000 Jan.

 1264.      De Meyer S.  Depla E.  Maertens G.  Soumillion A.  Yap SH. Characterization of small hepatitis B surface antigen epitopes involved in binding to human annexin V. Journal of Viral Hepatitis.  6(4):277-85, 1999 Jul.

 1265.      Degos F.  Christidis C.  Ganne-Carrie N.  Farmachidi JP.  Degott C. Guettier C.  Trinchet JC.  Beaugrand M.  Chevret S. Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut.  47(1):131-6, 2000 Jul.

 1266.      El Mir S.  Triebel F. A soluble lymphocyte activation gene-3 molecule used as a vaccine adjuvant elicits greater humoral and cellular immune responses to both particulate  and soluble antigens. Journal of Immunology. 164(11):5583-9,2000 Jun 1.

 1267.      Fattori D.  Urbani A.  Brunetti M.  Ingenito R.  Pessi A.  Prendergast K.  Narjes F.  Matassa VG.  De Francesco R.  Steinkuhler C. Probing the active site of the hepatitis C virus serine protease by fluorescence resonance energy transfer. Journal of Biological Chemistry.  275(20):15106-13, 2000 May 19.

 1268.      Flint M.  McKeating JA. The role of the hepatitis C virus glycoproteins in infection. [Review] [95 refs] Reviews in Medical Virology.  10(2):101-17, 2000 Mar-Apr.

 1269.      Greaves M.Chronic urticaria. [Review] [64 refs] Journal of Allergy & Clinical Immunology.  105(4):664-72, 2000 Apr.

 1270.      Hass PL. Differentiation and diagnosis of jaundice. [Review] [29 refs] AACN Clinical Issues.  10(4):433-41, 1999 Nov.

 1271.      Haviv YS.  Sharkia M.  Galun E.  Safadi R. Pancreatitis following hepatitis A vaccination. European Journal of Medical Research.  5(5):229-30, 2000 May 23.

 1272.      Huang CJ.  Chen YH.  Ting LP. Hepatitis B virus core protein interacts with the C-terminal region of actin-binding protein. Journal of Biomedical Science.  7(2):160-8, 2000 Mar-Apr.

 1273.      Kessel A.  Rosner I.  Zuckerman E.  Golan TD.  Toubi E. Use of antikeratin antibodies to distinguish between rheumatoid arthritis and polyarthritis associated with hepatitis C infection. Journal of Rheumatology.  27(3):610-2, 2000 Mar.

 1274.      Kimura Y.  Hayashida K.  Ishibashi H.  Niho Y.  Yanagi Y. Antibody-free virion titer greatly differs between hepatitis C virus genotypes.Journal of Medical Virology.  61(1):37-43, 2000 May.

 1275.      Lakshman M.  Nichter M. Contamination of medicine injection paraphernalia used by registered medical practitioners in south India: an ethnographic study.  Social Science & Medicine.  51(1):11-28, 2000 Jul.

 1276.      Lakshmi G.  Reddy RP.  Kumar KK.  Bhavani NV.  Dayanand M. Study of the safety, immunogenicity and seroconversion of a hepatitis-B vaccine in malnourished children of India. Vaccine.  18(19):2009-14, 2000 Apr 3.

 1277.      Lima AR.  Lima MS.  Soares BG.  Churchill R.  Farrell M. Carbamazepine for cocaine dependence. [Review] [6 refs] Cochrane Database of Systematic Reviews [computer file].  (2):CD002023, 2000.

 1278.      Linder N.  Handsher R.  German B.  Sirota L.  Bachman M.  Zinger S. Mendelson E.  Barzilai A. Controlled trial of immune response of preterm infants to recombinant  hepatitis B and inactivated poliovirus vaccines administered simultaneously shortly after birth. Archives of Disease in Childhood Fetal & Neonatal Edition.  83(1):F24-7, 2000 Jul.

 1279.      Lindgren S.  Nilsson S.  Nassberger L.  Verbaan H.  Wieslander J. Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club (SILK) [see comments]. Journal of Gastroenterology & Hepatology.  15(4):437-42, 2000 Apr.

 1280.      Lodha R.  Bagga A. Traditional Indian systems of medicine. [Review] [52 refs] Annals of the Academy of Medicine, Singapore.  29(1):37-41, 2000 Jan.

 1281.      MacLennan JM.  Shackley F.  Heath PT.  Deeks JJ.  Flamank C.  Herbert M. Griffiths H.  Hatzmann E. Goilav C.  Moxon ER. Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial [see comments]. JAMA. 283(21):2795-801, 2000 Jun 7.

 1282.      Mahoney RT.  Ramachandran S.  Xu Z.The introduction of new vaccines into developing countries II. Vaccine financing. [Review] [38 refs] Vaccine.  18(24):2625-35, 2000 Jun 1.

 1283.      Matsuo I.  Ikuno N.  Omagari K.  Kinoshita H.  Oka M.  Yamaguchi H.  Kohno  S.  Mackay IR. Autoimmune reactivity of sera to hepatocyte plasma membrane in type 1 autoimmune hepatitis [see comments]. Journal of Gastroenterology.  35(3):226-34, 2000.

 1284.      Milkiewicz P.  Mutimer D.  Hubscher SG.  Elias E. Autoimmune liver disease in patients with neoplastic diseases. European Journal of Gastroenterology & Hepatology.  11(5):569-73, 1999  May.

 1285.      Modahl LE.  Lai MM. Hepatitis delta virus: the molecular basis of laboratory diagnosis. [Review] [203 refs] Critical Reviews in Clinical Laboratory Sciences.  37(1):45-92, 2000 Feb.

 1286.      Muratori L.  Parola M.  Ripalti A.  Robino G.  Muratori P.  Bellomo G. Carini R.  Lenzi M.  Landini MP.  Albano E.  Bianchi FB. Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane [see comments]. Gut.  46(4):553-61, 2000 Apr.

 1287.      Narula AS; Chaudhury NR; Thakur SK; Karloopia SD; Kolhe VS; Chauhan SS Chronic hepatitis in patients of chronic renal failure. Medical Journal Armed Forces India 1998 Apr; 54(2): 148-50

 1288.      Obermayer-Straub P.  Strassburg CP.  Manns MP. Target proteins in human autoimmunity: cytochromes P450 and UDP- glucuronosyltransferases. [Review] [112 refs] Canadian Journal of Gastroenterology.  14(5):429-39, 2000 May.

 1289.      Pessayre D.  Mansouri A.  Haouzi D.  Fromenty B. Hepatotoxicity due to mitochondrial dysfunction. [Review] [47 refs]  Cell Biology & Toxicology.  15(6):367-73, 1999.

 1290.      Ray RB.  Meyer K.  Ray R. Hepatitis C virus core protein promotes immortalization of primary human hepatocytes. Virology.  271(1):197-204, 2000 May 25.

 1291.      Roberts EA. Autoimmune hepatitis. [Review] [39 refs] Indian Journal of Pediatrics.  62(5):525-31, 1995 Sep-Oct.

 1292.      Safary A.  Beck J. Vaccination against hepatitis B: current challenges for Asian countries  and future directions. [Review] [40 refs] Journal of Gastroenterology & Hepatology.  15(4):396-401, 2000 Apr.

 1293.      Shamsuzzaman SM.  Haque R.  Hasin SK.  Hashiguchi Y. Evaluation of indirect fluorescent antibody test and enzyme-linked immunosorbent assay for diagnosis of hepatic amebiasis in Bangladesh. Journal of Parasitology.  86(3):611-5, 2000 Jun.

 1294.      Sharara AI. Diagnosis and management of chronic hepatitis C. [Review] [32 refs] Journal Medical Libanais - Lebanese Medical Journal.  47(6):339-42, 1999 Nov-Dec.

 1295.      Strickland DK.  Riely CA.  Patrick CC.  Jones-Wallace D.  Boyett JM. Waters B.  Fleckenstein JF.  Dean PJ.  Davila R.  Caver TE.  Hudson MM. Hepatitis C infection among survivors of childhood cancer. Blood.  95(10):3065-70, 2000 May 15.

 1296.      Takeda K.  Hayakawa Y.  Van Kaer L.  Matsuda H.  Yagita H.  Okumura K. Critical contribution of liver natural killer T cells to a murine model of  hepatitis. Proceedings of the National Academy of Sciences of the United States of America.  97(10):5498-503, 2000 May 9.

 1297.      Tarao K.  Rino Y.  Takemiya S.  Tamai S.  Ohkawa S.  Sugimasa Y.  Miyakawa K.  Morinaga S.  Yoshida M.  Shibuya A.  Kokubu S.  Kakita A.  Endo O. Close association between high serum ALT and more rapid recurrence of  hepatocellular carcinoma in hepatectomized patients with HCV-associated  liver cirrhosis and hepatocellular carcinoma.  Intervirology.  43(1):20-6, 2000.

 1298.      Ulmer SC. Hepatocellular carcinoma. A concise guide to its status and management. [Review] [24 refs] Postgraduate Medicine.  107(5):117-24, 2000 May 1.

 1299.      Vyas GN. Immunobiology of persistent blood-borne viral infections. [Review] [17 refs] Developments in Biological Standardization.  102:9-17, 2000.

 1300.      Walsh K.  Alexander G. Alcoholic liver disease. [Review] [45 refs] Postgraduate Medical Journal.  76(895):280-6, 2000 May.

 1301.      Ward BJ. Vaccine adverse events in the new millennium: is there reason for concern? [see comments]. [Review] [62 refs] Bulletin of the World Health Organization.  78(2):205-15, 2000.

 1302.      Widera G.  Austin M.  Rabussay D.  Goldbeck C.  Barnett SW.  Chen M.  Leung L.  Otten GR.  Thudium K.  Selby MJ.  Ulmer JB. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. Journal of Immunology.  164(9):4635-40, 2000 May 1.

 1303.      Wies I.  Brunner S.  Henninger J.  Herkel J.  Kanzler S.  Meyer zum Buschenfelde KH.  Lohse AW. Identification of target antigen for SLA/LP autoantibodies in autoimmune  hepatitis [see comments]. Lancet.  355(9214):1510-5, 2000 Apr 29.

 1304.      Ying C.  De Clercq E.  Neyts J. Lamivudine, adefovir and tenofovir exhibit long-lasting anti-hepatitis B virus activity in cell culture. Journal of Viral Hepatitis.  7(1):79-83, 2000 Jan.

 1305.      Zucca E.  Roggero E.  Maggi-Solca N.  Conconi A.  Bertoni F.  Reilly I.  Castelli D.  Pedrinis E.  Piffaretti JC.  Cavalli F. Prevalence of Helicobacter pylori and hepatitis C virus infections among  non-Hodgkin's lymphoma patients in Southern Switzerland. Haematologica.  85(2):147-53, 2000 Feb.


  1686 Aizawa Y. Shibamoto Y. Takagi I. Zeniya M. Toda G. Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. A long term follow-up study after histologic diagnosis. Cancer.  89 ( 1 ) : 53-9, 2000 Jul 1.

 1687. Berenguer M. Prieto M. Rayon JM. Mora J. Pastor M.  Ortiz V.  Carrasco D.  San Juan  F.   Burgueno  MD.   Mir  J .   Berenguer  J.   Natural    history   of   clinically compensated  hepatitis  C  virus-related  graft  cirrhosis after liver transplantation. Hepatology.  32(4 Pt 1):852-8, 2000 Oct.

 1688. Blatt LM. Mutchnick MG.  Tong MJ.  Klion FM.  Lebovics E.  Freilich B. Bach N. Smith C. Herrera J. Tobias H. Conrad A. Schmid P.McHutchison JG. Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States. Journal of Viral Hepatitis.  7(3):196-202, 2000 May.

 1689. Caniatti LM. Tugnoli V. Eleopra R. Tralli G. Bassi R. De Grandis D. Cryoglobulinemic neuropathy related to hepatitis C virus infection. Clinical, laboratory and neurophysiological study. Journal of the Peripheral Nervous System. 1(2):131-8, 1996.

 1690. Chattopadhyay D.  Sen MR.  Aryya NC.  Immunohistopathological  reactions  for liver-specific membrane lipo-protein in experimental autoimmune hepatitis.Indian Journal of Pathology & Microbiology.  42(3):291-7, 1999 Jul.

 1691. Cote PJ. Toshkov I. Bellezza C. Ascenzi M. Roneker C. Ann Graham L. Baldwin BH. Gaye K.  Nakamura I.  Korba BE.  Tennant BC.  Gerin JL. Temporal pathogenesis of  experimental  neonatal  woodchuck  hepatitis  virus  infection : increased initial viral  load  and  decreased  severity  of  acute  hepatitis  during  the development of chronic viral infection. Hepatology.  32(4 Pt 1):807-17, 2000 Oct.

 1692. de La Rosa JM.  Escobedo M. Tuberculosis and other  infectious  diseases  in  the adolescent immigrant. [Review] [23 refs] Adolescent Medicine.  11 ( 2 ) : 453-66, 2000 Jun.

 1693. Egner W. The use of laboratory tests in the diagnosis of SLE. [Review] [149 refs] Journal of Clinical Pathology.  53(6):424-32, 2000 Jun.

 1694. Griga T.  Tromm A.  Muller KM.  May B.Overlap syndrome between autoimmune hepatitis  and  primary  sclerosing  cholangitis  in  two  cases.  European Journal of Gastroenterology & Hepatology.  12(5):559-64, 2000 May.

 1695. Hayashi S.  Ohtake H.  Koike M. Laparoscopic  diagnosis  and  clinical  course  of chronic schistosomiasis japonica. Acta Tropica.  77(1):133-40, 2000 Oct 23.

 1696. Heile JM. Fong YL. Rosa D. Berger K. Saletti G. Campagnoli S. Bensi G. Capo S. Coates S. Crawford K. Dong C. Wininger M. Baker G. Cousens L. Chien D. Ng P. Archangel  P.  Grandi  G.  Houghton  M.  Abrignani  S.  Evaluation  of  hepatitis  C virus  glycoprotein  E2  for  vaccine  design :  an  endoplasmic  reticulum-retained recombinant protein is superior to secreted recombinant protein  and  DNA-based vaccine candidates. Journal of Virology.  74(15):6885-92, 2000 Aug.

 1697. Hilleman  MR.  Vaccines  in  historic  evolution  and  perspective :  a  narrative  of vaccine discoveries. Journal of Human Virology.  3(2):63-76, 2000 Mar-Apr.

 1698. Hwang SJ.  Luo JC.  Lai CR.  Chu CW.  Tsay SH.  Lu CL.  Wu JC.  Chang FY. Lee SD. Clinical, virologic and pathologic significance of elevated serum gamma-glutamyl transpeptidase in patients with chronic hepatitis C. Chung Hua i Hsueh Tsa Chih -Chinese Medical Journal.  63(7):527-35, 2000 Jul.

 1699. Imperiale TF.  Said AT.  Cummings OW.  Born LJ. Need for validation of clinical decision aids: use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C. American Journal of Gastroenterology.  95(9):2328-32, 2000 Sep.

 1700. Jacobs  RJ.   Margolis  HS.  Coleman  PJ.   The  cost-effectiveness  of  adolescent hepatitis A vaccination in states with the highest disease rates. Archives of Pediatrics & Adolescent Medicine.  154(8):763-70, 2000 Aug.

 1701. Jeffers  L. Hepatocellular  carcinoma :  an  emerging  problem  with  hepatitis  C. Journal of the National Medical Association.  92(8):369-71, 2000 Aug.

 1702. Kaakkola  S.  Clinical  pharmacology ,  therapeutic  use  and  potential  of  COMT inhibitors in Parkinson's disease. [Review] [109 refs]Drugs. 59(6) : 1233-50, 2000 Jun.

 1703. Kallinowski B. Knoll A.  Lindner E.  Sanger R.  Stremmel W.  Vollmar J. Zieger B. Jilg W.  Can monovalent hepatitis A and B vaccines  be  replaced  by  a  combined hepatitis  A/B  vaccine  during the primary immunization course?.Vaccine.  19(1): 16-22, 2000 Aug 15.

 1704. Konomi  N.  Yamaguchi  M.  Naito  H.   Aiba  N.   Saito  T.    Arakawa  Y.   Abe  K. Simultaneous detection of hepatitis B, C, and G viral genomes by multiplex PCR method. Japanese Journal of Infectious Diseases.  53(2):70-2, 2000 Apr.

 1705. Kumar KS.  Malet PF.Nonalcoholic steatohepatitis. [Review] [38 refs] Mayo Clinic Proceedings.  75(7):733-9, 2000 Jul.

 1706. Leung W.  Hudson MM.  Strickland DK.  Phipps S.  Srivastava DK.  Ribeiro RC. Rubnitz  JE.   Sandlund  JT.   Kun  LE.   Bowman  LC.   Razzouk  BI.   Mathew  P.  Shearer P.  Evans WE.  Pui CH. Late effects of treatment in survivors of childhood acute myeloid leukemia. Journal of Clinical Oncology. 18(18):3273-9,2000 Sep 15.

 1707. Louie M.  Louie L.  Simor AE. The role of DNA amplification technology in the diagnosis of infectious diseases. [Review] [81 refs] CMAJ. 163 ( 3 ) : 301-9, 2000 Aug 8.

 1708. Manoussakis MN. Moutsopoulos HM. Sjogren's syndrome: autoimmune epithelitis. Best Practice & Research in Clinical Rheumatology.  14(1):73-95, 2000 Mar.

 1709. Matheson AJ.  Goa KL.  Diphtheria-tetanus-acellular  pertussis  vaccine  adsorbed ( Triacelluvax ;  DTaP3-CB ) :  a  review of its use in the prevention of Bordetella pertussis infection. [Review] [50 refs] Paediatric Drugs. 2(2):139-59, 2000 Mar-Apr.

 1710. Matsumura H.  Moriyama M.  Goto I.  Tanaka N.  Okubo H.  Arakawa Y. Natural course  of  progression  of  liver  fibrosis  in  Japanese  patients  with  chronic  liver disease  type  C--a  study  of  527  patients  at  one  establishment.  Journal  of  Viral Hepatitis.  7(4):268-75, 2000 Jul.

 1711. Matsuoka S. Uchiyama K. Kuniyasu  Y. Niio  Y. Shima  H. Doai  K. Oishi  S.  Nojiri Y. Ogata   H.   Abnormal   pulmonary   accumulation   of   indium - 111   chloride  in pneumocystis   carinii   pneumonia   as   detected   by   bone   marrow   scintigraphy. Clinical Nuclear Medicine.  25(5):361-3, 2000 May.

 1712. Meral A.  Sevinir B.  Gunay U. Efficacy of immunization against hepatitis B virus infection in children with cancer.Medical & Pediatric Oncology. 35(1):47-51, 2000 Jul.

 1713. Merican I. Screening for hepatocellular carcinoma. Medical Journal of Malaysia. 51(1):12-7, 1996 Mar.

 1714. Milkiewicz   P.   Saksena   S.   Hubscher   SG.   Elias  E.   Wilson's   disease   with superimposed  autoimmune  features :  report  of  two  cases  and  review. [Review] [17 refs] Journal of Gastroenterology & Hepatology.  15(5):570-4, 2000 May.

 1715. Minutello M.  Zotti C.  Orecchia S.  Di Martino E.  Bastianoni I.  Ypma E.  Ruggenini Moiraghi A.  Podda A.  Dose  range  evaluation  of  a  new  inactivated  hepatitis  A vaccine administered as a single dose followed by a booster. Vaccine.  19(1):10-5, 2000 Aug 15.

 1716. O'Beirne J. Patch D.  Holt S.  Hamilton M.  Burroughs AK. Alcoholic hepatitis-the case for intensive management. [Review] [18 refs] Postgraduate Medical Journal. 76(898):504-7, 2000 Aug.

 1717. Ohta A.  Sekimoto M.  Sato M.  Koda T.  Nishimura S.  Iwakura Y.  Sekikawa K. Nishimura T.  Indispensable  role  for  TNF-alpha  and  IFN-gamma  at the effector phase of liver injury mediated by Th1 cells  specific  to  hepatitis  B  virus  surface antigen. Journal of Immunology.  165(2):956-61, 2000 Jul 15.

 1718. OiConnor  JA.  Acute and chronic viral hepatitis. [ Review ]  [ 30 refs ] Adolescent Medicine.  11(2):279-92, 2000 Jun.

 1719. Par A. Diagnosis  and  management  of  chronic hepatitis C. [ Review ]  [ 33 refs ] Canadian Journal of Gastroenterology.  14 Suppl B:83B-88B, 2000 Jul-Aug.

 1720. Roca B.  Gomez CJ.  Arnedo A.Adherence, side effects and efficacy of stavudine plus lamivudine plus nelfinavir  in  treatment-experienced  HIV-infected  patients. Journal of Infection.  41(1):50-4, 2000 Jul.

 1721. Roeckel  IE.  Commentary :  Iron  metabolism in hepatitis C infection. [ Review ][11 refs] Annals of Clinical & Laboratory Science.  30(2):163-5, 2000 Apr.

 1722. Rosen HR. Gretch D. Kaufman E. Quan S.Humoral immune response to hepatitis  C after liver transplantation: assessment of a new recombinant immunoblot assay. American Journal of Gastroenterology.  95(8):2035-9, 2000 Aug.

 1723. Roubalova K.  Suchankova A.  Vitek A.  Sajdova J.  Presence  of  herpes  simplex virus  ( HSV )  in  peripheral  leukocytes  of  patient  who  developed  active  HSV infection after bone marrow transplantation. Journal of Clinical Virology. 17 (1) 37-42, 2000 Jun.

 1724. Schmitt HJ.  Knuf M.  Ortiz E.  Sanger R.  Uwamwezi MC.  Kaufhold A.Primary vaccination   of   infants   with   diphtheria-tetanus-acellular   pertussis-hepatitis   B virus-inactivated polio virus and Haemophilus influenzae type b vaccines given a either separate or mixed injections [see comments].Journal of Pediatrics.  137(3): 304-12, 2000 Sep.

 1725. Seeto RK.  Fenn B.  Rockey DC.  Ischemic  hepatitis :  clinical  presentation  and pathogenesis. American Journal of Medicine.  109(2):109-13, 2000 Aug 1.

 1726. Seltsam A.  Shukry-Schulz S.  Salama A. Vaccination-associated immune hemolytic anemia in two children. Transfusion.  40(8):907-9, 2000 Aug.

 1727. Stevens AB.  Coyle PV.  Hepatitis  C virus :  an  important  occupational  hazard ?. [Review] [74 refs] Occupational Medicine (Oxford).  50(6):377-82, 2000 Aug.

 1728. Strassburg   CP.  Manns  MP.   Autoimmune   tests   in   primary   biliary   cirrhosis. [Review] [80 refs] Best Practice & Research in Clinical Gastroenterology.  14(4): 585-99, 2000 Aug.

 1729. Tanaka E.  Ohue C.  Aoyagi K.  Yamaguchi  K.  Yagi  S.   Kiyosawa  K.  Alter  HJ. Evaluation  of  a  new  enzyme  immunoassay  for  hepatitis  C  virus  (HCV)  core antigen with clinical sensitivity approximating that of  genomic  amplification  of HCV RNA.Hepatology.  32(2):388-93, 2000 Aug.

 1730. Tanaka  H.  Tsukuma  H.  Kasahara  A.  Hayashi  N.  Yoshihara  H.  Masuzawa  M. Kanda T.  Kashiwagi T.  Inoue A.  Kato M.  Oshima A.  Kinoshita Y.  Kamada T. Effect  of  interferon  therapy  on  the  incidence of  hepatocellular  carcinoma  and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patients. International Journal of Cancer.  87(5):741-9, 2000 Sep 1.

 1731. Teixeira R. Pastacaldi S. Papatheodoridis GV. Burroughs AK. Recurrent hepatitis  C after liver transplantation. [ Review ]  [ 112  refs ]  Journal of Medical Virology. 61(4):443-54, 2000 Aug.

 1732. Thobe N.  Pilger P.  Jones MP. Primary hypothyroidism masquerading as hepatic encephalopathy: case report  and  review  of  the  literature.  [ Review ]  [ 13 refs Postgraduate Medical Journal.  76(897):424-6, 2000 Jul.

 1733. Wang F.  Yoshida I.  Takamatsu M.  Ishido S.  Fujita T.  Oka K.  Hotta H.Complex formation  between  hepatitis  C  virus  core  protein  and  p21 Waf1 / Cip1 / Sdi1. Biochemical & Biophysical Research Communications.  273(2):479-84, 2000 Jul 5.

 1734. Woo  PC.  Tsoi   HW.   Leung  HC.    Wong  LP.    Wong   SS.    Chan E.  Yuen KY.  Enhancement by ampicillin of antibody responses induced  by  a  protein  antigen and a DNA vaccine carried by live-attenuated Salmonella enterica serovar Typhi. Clinical & Diagnostic Laboratory Immunology.  7(4):596-9, 2000 Jul.

 1735. Yamaguchi N. Tokushige K.  Yamauchi K.  Hayashi N. Humoral immune response in  Japanese  acute  hepatitis  patients  with  hepatitis  C  virus  infection. Canadian Journal of Gastroenterology.  14(7):593-8, 2000 Jul-Aug.

 1736. Zeuzem S. Gut-liver axis. [Review] [301 refs] International Journal of Colorectal Disease.  15(2):59-82, 2000 Apr.

2189.      Bilezikci B.  Haberal AN.  Demirhan B. Hepatocyte growth factor in patients with three different stages of chronic liver disease including hepatocellular carcinoma, cirrhosis and chronic hepatitis: an immunohistochemical study.  Canadian Journal of Gastroenterology.  15(3):159-65, 2001 Mar.

2190.      Chan AY.  Dieckhaus KD.  Ramsey WH.  Cytomegalovirus hepatitis in a nontransplant patient with autoimmune hepatitis taking immunosuppressants.  American Journal of Gastroenterology.  96(1):262-3, 2001 Jan.

2191.      High KA. Gene transfer as an approach to treating hemophilia. [Review] [70 refs] Circulation Research.  88(2):137-44, 2001 Feb 2.

2192.      Kato Y.  Nakata K.  Omagari K.  Kusumoto Y.  Mori I.  Furukawa R.  Tanioka H.  Tajima H.  Yano M.  Eguchi K. Clinical features of fulminant hepatitis in Nagasaki Prefecture, Japan.  Internal Medicine.  40(1):5-8, 2001 Jan.

2193.      Malik AH.  Collins RH Jr.  Saboorian MH.  Lee WM. Chronic graft-versus-host disease after hematopoietic cell transplantation presenting as an acute hepatitis.   American Journal of Gastroenterology.  96(2):588-90, 2001 Feb.

2194.      Neubauer K.  Saile B.  Ramadori G. Liver fibrosis and altered matrix synthesis. [Review] [75 refs]  Canadian Journal of Gastroenterology.  15(3):187-93, 2001 Mar.

2195.      Sanyal A.  Nonalcoholic steatohepatitis. [Review] [79 refs] Indian Journal of Gastroenterology.  20 Suppl 1:C64-70, 2001 Mar.

2196.      Senyuz OF.  Yesildag E.  Emir H.  Tekant G.  Bozkurt P.  Sarimurat N.  Soylet Y.  Diagnostic laparoscopy in prolonged jaundice.  Journal of Pediatric Surgery.  36(3):463-5, 2001 Mar.

2197.      Yoon SN.  Yoo BM.  Hwang KH.  Hepatobiliary scintigraphy showing acute complete common bile duct obstruction in a patient with acute hepatitis.  Clinical Nuclear Medicine.  26(2):151-2, 2001 Feb.

2198.      Zen Y.  Katayanagi K.  Tsuneyama K.  Harada K.  Araki I.  Nakanuma Y.  Hepatocellular carcinoma arising in non-alcoholic steatohepatitis.  Pathology International.  51(2):127-31, 2001 Feb.

2741.      Abass F.  Thomas RD.  Rajkumar A.  Gupta N.  Puliyel JM. Controlling perinatally acquired hepatitis B. Indian Journal of Pediatrics.  68(4):365, 2001 Apr.

2742.      Ahmed A.  Samuels SL.  Keeffe EB.  Cheung RC. Delayed fatal hemorrhage from pseudoaneurysm of the hepatic artery after percutaneous liver biopsy. American Journal of Gastroenterology.  96(1):233-7, 2001 Jan.

2743.      Alper J. Searching for medicine's sweet spot. Science.  291(5512):2338-43, 2001 Mar 23.

2744.      Anonymous. From the Centers for Disease Control and Prevention. Impact of the 1999 AAP/USPHS Joint Statement on Thimerosal in Vaccines on Infant Hepatitis B Vaccination Practices. American Academy of Pediatrics/U.S. Public Health Service.  JAMA.  285(12):1568-70, 2001 Mar 28.

2745.      Anonymous. From the Centers for Disease Control and Prevention. Recommended childhood immunization schedule--United States, 2001. JAMA. 285(7):875-6, 2001 Feb 21.

2746.      Anonymous. Impact of the 1999 AAP/USPHS joint statement on thimerosal in vaccines on infant hepatitis B vaccination practices. MMWR - Morbidity & Mortality Weekly Report.  50(6):94-7, 2001 Feb 16.

2747.      Anonymous. Recommended childhood immunization schedule--United States, 2001. MMWR - Morbidity & Mortality Weekly Report.  50(1):7-10, 19, 2001 Jan 12.

2748.      Ascherio A.  Zhang SM.  Hernan MA.  Olek MJ.  Coplan PM.  Brodovicz K.  Walker AM.  Hepatitis B vaccination and the risk of multiple sclerosis. [see comments]. New England Journal of Medicine.  344(5):327-32, 2001 Feb 1.

2749.      Authier FJ.  Cherin P.  Creange A.  Bonnotte B.  Ferrer X.  Abdelmoumni A.  Ranoux D.  Pelletier J.  Figarella-Branger D.  Granel B.  Maisonobe T.  Coquet M.  Degos JD.  Gherardi RK. Central nervous system disease in patients with macrophagic myofasciitis. Brain.  124(Pt 5):974-83, 2001 May.

2750.      Bah E.  Parkin DM.  Hall AJ.  Jack AD.  Whittle H. Cancer in the Gambia: 1988-97.  British Journal of Cancer.  84(9):1207-14, 2001 May 4.

2751.      Bates I.  Bedu-Addo G.  Jarrett RF.  Schulz T.  Wallace S.  Armstrong A.  Sheldon J.  Rutherford T.  B-lymphotropic viruses in a novel tropical splenic lymphoma. British Journal of Haematology.  112(1):161-6, 2001 Jan.

2752.      Berger A.  Preiser W.  Doerr HW. The role of viral load determination for the management of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection. [Review] [39 refs]  Journal of Clinical Virology.  20(1-2):23-30, 2001 Jan.

2753.      Brecher LS.  Cymet TC. A practical approach to fibromyalgia. [Review] [45 refs]  Journal of the American Osteopathic Association.  101(4 Suppl Pt 2):S12-7, 2001 Apr.

2754.      Bryan JP.  McCardle P.  South-Paul JE.  Fogarty JP.  Legters LJ.  Perine PL. Randomized controlled trial of concurrent hepatitis A and B vaccination. Military Medicine.  166(2):95-101, 2001 Feb.

2755.      Caldwell SH.  Hespenheide EE.  von Borstel RW. Myositis, microvesicular hepatitis, and progression to cirrhosis from troglitazone added to simvastatin. Digestive Diseases & Sciences.  46(2):376-8, 2001 Feb.

2756.      Calleja JL.  Albillos A.  Rossi I.  Moreno R.  Domper F.  Martinez JL.  Escartin P. Time course of serum hepatitis C virus-RNA during chronic hepatitis C treatment accurately predicts the type of response. Alimentary Pharmacology & Therapeutics.  15(2):241-9, 2001 Feb.

2757.      Chan CH.  Hadlock KG.  Foung SK.  Levy S. V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen. Blood.  97(4):1023-6, 2001 Feb 15.

2758.      Chodick G.  Lerman Y.  Peled T.  Aloni H.  Ashkenazi S. Cost-benefit analysis of active vaccination campaigns against hepatitis A among daycare centre personnel in Israel.  Pharmacoeconomics.  19(3):281-91, 2001.

2759.      Christenson  JC.  Fischer  PR.  Hale  DC.  Derrick  D. Pediatric travel consultation in an integrated clinic.  Journal of Travel Medicine.  8(1):1-5, 2001 Jan-Feb.

2760.      Colombo M. Screening for cancer in viral hepatitis. [Review] [60 refs] Clinics in Liver Disease.  5(1):109-22, 2001 Feb.

2761.      Daar ES.  Lynn H.  Donfield S.  Gomperts E.  Hilgartner MW.  Hoots WK.  Chernoff D.  Arkin S.  Wong WY.  Winkler CA.  The Hemophilia Growth and Development Study.   Relation between HIV-1 and hepatitis C viral load in patients with hemophilia.  Journal of Acquired Immune Deficiency Syndromes.  26(5):466-72, 2001 Apr 15.

2762.      Davidovici B.  Karakis I.  Bourboulia D.  Ariad S.  Zong J.  Benharroch D.  Dupin N.  Weiss R.  Hayward G.  Sarov B.  Boshoff C. Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel.  Journal of the National Cancer Institute.  93(3):194-202, 2001 Feb 7.

2763.      Doshi AV.  Desai D.  Bhaduri A.  Udwadia ZF. Lymphocytic interstitial pneumonitis associated with autoimmune hepatitis. Indian Journal of Gastroenterology.  20(2):76-7, 2001 Mar-Apr.

2764.      Dudas J.  Kovalszky I.  Gallai M.  Nagy JO.  Schaff Z.  Knittel T.  Mehde M.  Neubauer K.  Szalay F.  Ramadori G. Expression of decorin, transforming growth factor-beta 1, tissue inhibitor metalloproteinase 1 and 2, and type IV collagenases in chronic hepatitis.  American Journal of Clinical Pathology.  115(5):725-35, 2001 May.

2765.      Ericsson  CD. Travel medicine: key to improved adult vaccination against Hepatitis A and B. [letter; comment].  Journal of Travel Medicine.  8 Suppl 1:S1-2, 2001 Jan.

2766.      Faustini A.  Franco E.  Sangalli M.  Spadea T.  Calabrese RM.  Cauletti M.  Perucci CA. Persistence of anti-HBs 5 years after the introduction of routine infant and adolescent vaccination in Italy. Vaccine.  19(20-22):2812-8, 2001 Apr 6.

2767.      Fisher MA.  Eklund SA.  James SA.  Lin X. Adverse events associated with hepatitis B vaccine in U.S. children less than six years of age, 1993 and 1994. Annals of Epidemiology.  11(1):13-21, 2001 Jan.

2768.      Fracanzani AL.  Conte D.  Fraquelli M.  Taioli E.  Mattioli M.  Losco A.  Fargion S. Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease. Hepatology.  33(3):647-51, 2001 Mar.

2769.      Gilbert P.  Self S.  Rao M.  Naficy A.  Clemens J. Sieve analysis: methods for assessing from vaccine trial data how vaccine efficacy varies with genotypic and phenotypic pathogen variation. [Review] [65 refs] Journal of Clinical Epidemiology.  54(1):68-85, 2001 Jan.

2770.      Gout O. Vaccinations and multiple sclerosis. New England Journal of Medicine.  344(23):1794; discussion 1795, 2001 Jun 7.

2771.      Harcourt C.  van Beek I.  Heslop J.  McMahon M.  Donovan B. The health and welfare needs of female and transgender street sex workers in New South Wales. Australian & New Zealand Journal of Public Health.  25(1):84-9, 2001.

2772.      Herold C.  Heinz R.  Radespiel-Troger M.  Schneider HT.  Schuppan D.  Hahn EG. Quantitative testing of liver function in patients with cirrhosis due to chronic hepatitis C to assess disease severity. Liver.  21(1):26-30, 2001 Feb.

2773.      Hostetler L. Vaccinations and multiple sclerosis. New England Journal of Medicine.  344(23):1795, 2001 Jun 7.

2774.      Hsu HM.  Lee SC.  Wang MC.  Lin SF.  Chen DS. Efficacy of a mass hepatitis B immunization program after switching to recombinant hepatitis B vaccine: a population-based study in Taiwan.  Vaccine.  19(20-22):2825-9, 2001 Apr 6.

2775.      Imbert-Bismut F.  Ratziu V.  Pieroni L.  Charlotte F.  Benhamou Y.  Poynard T.  MULTIVIRC Group. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet.  357(9262):1069-75, 2001 Apr 7.

2776.      Iwata M.  Sasaki M.  Harada K.  Kaneko S.  Kobayashi K.  Adachi K.  Sasaki M.  Nakanuma Y. Intrahepatic cholangitis and arteritis after transcatheter arterial embolization in a patient with tumor-like lesion-associated autoimmune hepatitis. Pathology, Research & Practice.  197(1):59-63, 2001.

2777.      Jonsson JR.  Hong C.  Purdie DM.  Hawley C.  Isbel N.  Butler M.  Balderson GA.  Clouston AD.  Pandeya N.  Stuart K.  Edwards-Smith C.  Crawford DH.  Fawcett J.  Powell EE. Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantation. Liver Transplantation.  7(3):255-63, 2001 Mar.

2778.      Jungkind D. Automation of laboratory testing for infectious diseases using the polymerase chain reaction-- our past, our present, our future. [Review] [16 refs]  Journal of Clinical Virology.  20(1-2):1-6, 2001 Jan.

2779.      Kalkeri G.  Khalap N.  Garry RF.  Fermin CD.  Dash S. Hepatitis C virus protein expression induces apoptosis in HepG2 cells. Virology.  282(1):26-37, 2001 Mar 30.

2780.      Kita H.  Mackay IR.  Van De Water J.  Gershwin ME.  The lymphoid liver: considerations on pathways to autoimmune injury. [Review] [140 refs]  Gastroenterology.  120(6):1485-501, 2001 May.

2781.      Kulkarni R.  Scott-Emuakpor AB.  Brody H.  Weil WB.  Ragni MV.  Gera R.  Nondisclosure of human immunodeficiency virus and hepatitis C virus coinfection in a patient with hemophilia: medical and ethical considerations. Journal of Pediatric Hematology/Oncology.  23(3):153-8, 2001 Mar-Apr.

2782.      Lee CH.  Choi YH.  Yang SH.  Lee CW.  Ha SJ.  Sung YC. Hepatitis C virus core protein inhibits interleukin 12 and nitric oxide production from activated macrophages. Virology.  279(1):271-9, 2001 Jan 5.

2783.      Lerose R.  Molinari R.  Rocchi E.  Manenti F.  Villa E. Prognostic features and survival of hepatocellular carcinoma in Italy: impact of stage of disease. European Journal of Cancer.  37(2):239-45, 2001 Jan.

2784.      Liu ZX.  Govindarajan S.  Okamoto S.  Dennert G. Fas-mediated apoptosis causes elimination of virus-specific cytotoxic T cells in the virus-infected liver. Journal of Immunology.  166(5):3035-41, 2001 Mar 1.

2785.      Macdonald GA. Pathogenesis of hepatocellular carcinoma. [Review] [106 refs] Clinics in Liver Disease.  5(1):69-85, 2001 Feb.

2786.      Maddrey WC. Hepatitis B--an important public health issue. [Review] [33 refs]  Clinica y Laboratorio.  47(1-2):51-5, 2001.

2787.      Majumder M.  Ghosh AK.  Steele R.  Ray R.  Ray RB. Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner.  Journal of Virology.  75(3):1401-7, 2001 Feb.

2788.      Marie I.  Levesque H.  Tranvouez JL.  Francois A.  Riachi G.  Cailleux N.  Courtois H.  Autoimmune hepatitis and systemic sclerosis: a new overlap syndrome?. Rheumatology (Oxford).  40(1):102-6, 2001 Jan.

2789.      Meng SD.  Gao T.  Gao GF.  Tien P. HBV-specific peptide associated with heat-shock protein gp96. Lancet.  357(9255):528-9, 2001 Feb 17.

2790.      Minkovitz CS.  Belote AD.  Higman SM.  Serwint JR.  Weiner JP. Effectiveness of a practice-based intervention to increase vaccination rates and reduce missed opportunities. Archives of Pediatrics & Adolescent Medicine.  155(3):382-6, 2001 Mar.

2791.      Oram RJ.  Daum RS.  Seal JB.  Lauderdale DS. Impact of recommendations to suspend the birth dose of hepatitis B virus vaccine.  JAMA.  285(14):1874-9, 2001 Apr 11.

2792.      Park GJ.  Mann SP.  Ngu MC. Acute hepatitis induced by Shou-Wu-Pian, a herbal product derived from Polygonum multiflorum. Journal of Gastroenterology & Hepatology.  16(1):115-7, 2001 Jan.

2793.      Perrillo RP. Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease. [Review] [124 refs] Gastroenterology.  120(4):1009-22, 2001 Mar.

2794.      Post JJ.  Dolan KA.  Whybin LR.  Carter IW.  Haber PS.  Lloyd AR. Acute hepatitis C virus infection in an Australian prison inmate: tattooing as a possible transmission route. Medical Journal of Australia.  174(4):183-4, 2001 Feb 19.

2795.      Randhawa P.  Blakolmer K.  Kashyap R.  Raikow R.  Nalesnik M.  Demetris AJ.  Jain A. Allograft liver biopsy in patients with Epstein-Barr virus-associated posttransplant lymphoproliferative disease. American Journal of Surgical Pathology.  25(3):324-30, 2001 Mar.

2796.      Rayes N.  Seehofer D.  Hopf U.  Neuhaus R.  Naumann U.  Bechstein WO.  Neuhaus P.   Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantation.  Transplantation.  71(1):96-101, 2001 Jan 15.

2797.      Read SJ. Recovery efficiences on nucleic acid extraction kits as measured by quantitative LightCycler PCR. Molecular Pathology.  54(2):86-90, 2001 Apr.

2798.      Rinaldi M.  Ria F.  Parrella P.  Signori E.  Serra A.  Ciafre SA.  Vespignani I.  Lazzari M.  Farace MG.  Saglio G.  Fazio VM. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells. Cancer Research.  61(4):1555-62, 2001 Feb 15.

2799.      Schaffer JV.  Davidson DM.  McNiff JM.  Bolognia JL. Perinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris. Journal of the American Academy of Dermatology.  44(2):198-206, 2001 Feb.

2800.      Shor A. A pathologist's view of organisms and human atherosclerosis. Journal of Infectious Diseases.  183(9):1428-9, 2001 May 1.

2801.      Siddiqui F.  Mutchnick M.  Kinzie J.  Peleman R.  Naylor P.  Ehrinpreis M. Prevalence of hepatitis A virus and hepatitis B virus immunity in patients with polymerase chain reaction-confirmed hepatitis C: implications for vaccination strategy. American Journal of Gastroenterology.  96(3):858-63, 2001 Mar.

2802.      Smieja M.  Cronin L.  Levine M.  Goldsmith CH.  Yusuf S.  Mahony JB. Previous exposure to Chlamydia pneumoniae, Helicobacter pylori and other infections in Canadian patients with ischemic heart disease.  Canadian Journal of Cardiology.  17(3):270-6, 2001 Mar.

2803.      Soussan P.  Pol S.  Garreau F.  Brechot C.  Kremsdorf D. Vaccination of chronic hepatitis B virus carriers with preS2/S envelope protein is not associated with the emergence of envelope escape mutants.  Journal of General Virology.  82(Pt 2):367-71, 2001 Feb.

2804.      Sturkenboom MC.  Fourrier A.  Vaccinations and multiple sclerosis. New England Journal of Medicine.  344(23):1794; discussion 1795, 2001 Jun 7.

2805.      Tseng CT.  Miskovsky E.  Houghton M.  Klimpel GR. Characterization of liver T-cell receptor gammadelta T cells obtained from individuals chronically infected with hepatitis C virus (HCV): evidence for these T cells playing a role in the liver pathology associated with HCV infections.  Hepatology.  33(5):1312-20, 2001 May.

2806.      Ulrich RG.  Bacon JA.  Brass EP.  Cramer CT.  Petrella DK.  Sun EL. Metabolic, idiosyncratic toxicity of drugs: overview of the hepatic toxicity induced by the anxiolytic, panadiplon. [Review] [73 refs] Chemico-Biological Interactions.  134(3):251-70, 2001 May 16.

2807.      Viswanathan C. Are our donors safe?. Indian Journal of Pediatrics.  68(1):69-75, 2001 Jan.

2808.      Walewski JL.  Keller TR.  Stump DD.  Branch AD. Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame.  Rna.  7(5):710-21, 2001 May.

2809.      Webster G.  Barnes E.  Dusheiko G.  Franklin I.  Protecting travellers from hepatitis A. BMJ.  322(7296):1194-5, 2001 May 19.

2810.      Weisbord JS.  Koumans EH.  Toomey KE.  Grayson C.  Markowitz LE. Sexually transmitted diseases during pregnancy: screening, diagnostic, and treatment practices among prenatal care providers in Georgia. Southern Medical Journal.  94(1):47-53, 2001 Jan.

2811.      Whitehead MW.  Hainsworth I.  Kingham JG. The causes of obvious jaundice in South West Wales: perceptions versus reality. Gut.  48(3):409-13, 2001 Mar.

2812.      Wickens K.  Crane J.  Kemp T.  Lewis S.  D'Souza W.  Sawyer G.  Stone L.  Tohill S.  Kennedy J.  Slater T.  Rains N.  Pearce N.  A case-control study of risk factors for asthma in New Zealand children.  Australian & New Zealand Journal of Public Health.  25(1):44-9, 2001.

2813.      Zhu J.  Nieto FJ.  Horne BD.  Anderson JL.  Muhlestein JB.  Epstein SE.  Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation.  103(1):45-51, 2001 Jan 2.


(Click Here for Abstract)

Back To Content Page